1. Home
  2. PRE

PRE

Prenetics Global Limited

Logo Prenetics Global Limited

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.

Founded: 2014 Country:
Hong Kong
Hong Kong
Employees: N/A City: N/A
Market Cap: 48.7M IPO Year: N/A
Target Price: $9.00 AVG Volume (30 days): 77.8K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -5.58 EPS Growth: N/A
52 Week Low/High: $3.25 - $15.90 Next Earning Date: 06-03-2024
Revenue: $21,742,675 Revenue Growth: 65.17%
Revenue Growth (this year): 1436.84% Revenue Growth (next year): -52.66%

Share on Social Networks: